ARTICLE | Company News

Knopp Neurosciences neurology news

October 25, 2010 7:00 AM UTC

Knopp Neurosciences transferred all assets, excluding dexpramipexole (KNS-760704), to new parent entity, Knopp Biosciences LLC, which will focus on expanding its drug discovery capabilities, including research activities directed at mitochondrial mechanisms of neurodegeneration and other diseases. The newco will be located at the same location as Knopp Neurosciences. ...